Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T7GV
|
|||
Former ID |
DNCL002618
|
|||
Drug Name |
Picoplatin
|
|||
Synonyms |
AMD 473; JM-473; ZD0473; (SP-4-3)-Amminedichloro(2-methylpyridine)platinium; Platinum, amminedichloro(2-methylpyridine)-, (SP-4-3)-; Picoplatin [INN:BAN]; UNII-B5TAN0L720; ZD 0473; AC1L42P3; B5TAN0L720; DB04874; Amminedichloro(2-methylpyridine)platinium; AN-30599; LS-184068; J-011604; azane; 2-methylpyridine; dichloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 3 | [1] | |
Ovarian cancer [ICD-11: 2C73; ICD-10: C56] | Phase 3 | [1] | ||
Prostate cancer [ICD-11: 2C82.0] | Phase 3 | [1] | ||
Small-cell lung cancer [ICD-11: 2C25.Y] | Phase 3 | [1] | ||
Company |
Ponaird Pharmaceuticals
|
|||
Structure |
Download2D MOL |
|||
Formula |
C6H10Cl2N2Pt
|
|||
Canonical SMILES |
CC1=CC=CC=N1.N.[Cl-].[Cl-].[Pt+2]
|
|||
InChI |
1S/C6H7N.2ClH.H3N.Pt/c1-6-4-2-3-5-7-6;;;;/h2-5H,1H3;2*1H;1H3;/q;;;;+2/p-2
|
|||
InChIKey |
IIMIOEBMYPRQGU-UHFFFAOYSA-L
|
|||
CAS Number |
CAS 181630-15-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00465491) Study of Picoplatin Efficacy After Relapse. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.